Landmark Melanoma Vaccine Could Be Available in Just 2 Years
Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer. Globally there were an estimated 325,000 new melanoma cases and 57 ,000…#moderna #stephanebancel #afp #bancel #rna #merck #keytruda #mrna4157 #massachusetts #fda
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Melanoma | Merck | Skin | Skin Cancer | Vaccines